Back to BLACKROCK ADVISORS LLC BLACKROCK ADVISORS LLC

NBIXNBIX

Showing 0 of 10 quarters

Position history for BLACKROCK ADVISORS LLCBLACKROCK ADVISORS LLC's holdings in NEUROCRINE BIOSCIENCES INC

As of its last 13F, for Q4 2016, BlackRock Advisors held 616,972 shares of NBIX (Neurocrine Biosciences), worth $23.9M. It reduced the position by 326,218 shares (-34.6%) from Q3 2016. BlackRock Advisors held NBIX from Q3 2014 to Q4 2016, across 10 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used